PEAK6 Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$657K Buy
+50,100
New +$551K ﹤0.01% 2337
2016
Q4
Sell
-12,000
Closed -$99K 4960
2016
Q3
$99K Hold
12,000
﹤0.01% 3569
2016
Q2
$96K Sell
12,000
-8,000
-40% -$64.1K ﹤0.01% 3596
2016
Q1
$135K Buy
+20,000
New +$132K ﹤0.01% 3407
2014
Q4
Sell
-14,700
Closed -$77K 4971
2014
Q3
$77K Buy
+14,700
New +$75.5K ﹤0.01% 3928

Other funds holding NEO

PEAK6 Group's NEO Position: Q4 2017 in Review

PEAK6 Group sold out of NeoGenomics (NEO) in Q4 2017, closing a stake of 53,217 shares — an estimated $592K sold.

PEAK6 Group first reported a position in NEO in Q3 2017 and held it in 1 quarter. The position peaked at $592K in Q3 2017. 132 funds tracked by Wall St. Rank hold NEO as of Q4 2017.

  • PEAK6 Group reported no remaining NeoGenomics position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 53,217 NeoGenomics shares in Q4 2017, an estimated $592K.
  • PEAK6 Group first reported a position in NeoGenomics in Q3 2017 and held it in 1 quarter.
  • PEAK6 Group's NeoGenomics position peaked at $592K in Q3 2017.
  • 132 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.